Clinical Trials
5 trialsNCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
NCT06256627 2024-02-13
The Maintenance Treatment of "ITIVA" in AML Patients
Henan Cancer Hospital
Phase NA Recruiting
NCT05266820 2022-03-18
Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT02733380 2020-04-01
Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03341494 2017-11-14
EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide
Fujian Cancer Hospital
Phase 2 Unknown